QuidelOrtho Corp (QDEL)
40.82
+0.42
(+1.04%)
USD |
NASDAQ |
Apr 24, 16:00
40.81
-0.01
(-0.02%)
After-Hours: 20:00
QuidelOrtho Research and Development Expense (Quarterly): 59.30M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 59.30M |
| September 30, 2023 | 62.40M |
| June 30, 2023 | 62.80M |
| March 31, 2023 | 62.30M |
| December 31, 2022 | 64.30M |
| September 30, 2022 | 65.60M |
| June 30, 2022 | 34.20M |
| March 31, 2022 | 26.40M |
| December 31, 2021 | 26.10M |
| September 30, 2021 | 23.70M |
| June 30, 2021 | 22.60M |
| March 31, 2021 | 23.30M |
| December 31, 2020 | 25.50M |
| September 30, 2020 | 21.45M |
| June 30, 2020 | 20.97M |
| March 31, 2020 | 16.38M |
| December 31, 2019 | 14.92M |
| September 30, 2019 | 11.98M |
| June 30, 2019 | 11.72M |
| March 31, 2019 | 13.93M |
| December 31, 2018 | 12.64M |
| September 30, 2018 | 13.10M |
| June 30, 2018 | 13.28M |
| March 31, 2018 | 12.62M |
| December 31, 2017 | 10.67M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.468M |
| June 30, 2017 | 7.627M |
| March 31, 2017 | 7.875M |
| December 31, 2016 | 7.508M |
| September 30, 2016 | 8.801M |
| June 30, 2016 | 9.656M |
| March 31, 2016 | 12.71M |
| December 31, 2015 | 9.939M |
| September 30, 2015 | 8.419M |
| June 30, 2015 | 9.105M |
| March 31, 2015 | 8.051M |
| December 31, 2014 | 9.199M |
| September 30, 2014 | 11.51M |
| June 30, 2014 | 8.127M |
| March 31, 2014 | 9.081M |
| December 31, 2013 | 11.29M |
| September 30, 2013 | 7.462M |
| June 30, 2013 | 7.945M |
| March 31, 2013 | 7.524M |
| December 31, 2012 | 7.283M |
| September 30, 2012 | 5.085M |
| June 30, 2012 | 6.844M |
| March 31, 2012 | 8.504M |
| December 31, 2011 | 6.766M |
| September 30, 2011 | 5.884M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
11.72M
Minimum
Jun 2019
65.60M
Maximum
Sep 2022
34.52M
Average
25.50M
Median
Dec 2020
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 684.00M |
| Becton Dickinson & Co | 290.00M |
| Boston Scientific Corp | 363.00M |
| Tenon Medical Inc | 0.691M |
| Perspective Therapeutics Inc | 6.08M |